Global Foot Care Products Industry

  • July 2014
  • -
  • Global Industry Analysts
  • -
  • 280 pages

This report analyzes the worldwide markets for Foot Care Products in US$ by the following Product Segments: Devices, and Medication. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 125 companies including many key and niche players such as -

Aetna Felt Corporation
Aetrex Worldwide, Inc.
Blistex Inc.
Chattem, Inc.
Footcare Express Inc.

Table Of Contents




I. INTRODUCTION, METHODOLOGY and PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation and Reporting Level I-2
Quantitative Techniques and Analytics I-3
Product Definitions and Scope of Study I-3
Devices I-3
Arch Bandage I-3
Arch Supports I-3
Corn Pain Relievers I-4
Orthotics I-4
Night Splint I-4
Medication I-4
Skin Antifungals I-4
Foot Antifungals I-4
Soft Gel Products I-4


II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW II-1
Foot Care Products Market - A Prelude II-1
US - The Single Largest Market II-2
Asia-Pacific - The Fastest Growing Market II-2
Table 1: Ten Largest Populated Countries Worldwide (July
2013): Total Population (in Millions) by Age Group 0-14
Years, 15-44 Years, 45-64 Years, and 65+ Years for China,
India, USA, Indonesia, Brazil, Pakistan, Nigeria,
Bangladesh, Russia and Japan (includes corresponding
Graph/Chart) II-3
Foot Care Segments Exhibiting Varied Growth Rates II-3
Impact of Global Recession on Foot Care Products Market II-4
Competitive Landscape II-4

2. TRENDS, DRIVERS and CHALLENGES II-5
Global Economy: A Key Growth Indicator II-5
Table 2: Economic Growth (%) Worldwide by Region: 2011-2014E
(includes corresponding Graph/Chart) II-6
Aging Population Offers Growth Prospects II-6
Table 3: Global Population Statistics for the 65+ Age Group
(Male and Female) for Major Countries/Regions: 2013E (includes
corresponding Graph/Chart) II-7

Table 4: Elderly Population (60+ Years) as a Percentage of
the Total Population: 2012 and 2050 (includes corresponding
Graph/Chart) II-8

Table 5: Life Expectancy at Age 60 and 80 Years- (2010-2015),
(2020-2025) and (2045-2050) (includes corresponding
Graph/Chart) II-9
The Emerging Middle Class in Developing Countries to Fuel Market II-9
Table 6: World Middle Class Population (2012 and 2030F):
Percentage Share Breakdown by Region - Asia-Pacific, Europe,
Latin America, Middle East and Africa and North America
(includes corresponding Graph/Chart) II-10
Mounting Healthcare Costs Spur Preference for Preventive
Healthcare II-10
Table 7: Healthcare Spending as a Percentage of GDP in Select
Countries (includes corresponding Graph/Chart) II-11
Women: An Important Consumer Cluster II-11
Table 8: Global Female Population (15 to 64 Years) by
Geographic Region: 2012 (in Million) (includes corresponding
Graph/Chart) II-13
Rising Interest in Grooming Among Men Signals Opportunities II-14
Table 9: Global Market for Men’s Grooming Products for 2012:
Percentage Share Breakdown of Value Sales by Geographic
Region - Western Europe, North America, Latin America,
Asia-Pacific, Eastern Europe and Middle East and Africa
(includes corresponding Graph/Chart) II-14
Product Innovations Pioneer Growth II-14
Innovations in Foot-Care Medication to Expand Opportunities II-14
Device Innovations - Key to Growth II-15
3D Orthotics - Transforming Custom Orthotics II-15
Advances in Materials to Drive Footwear Segment II-16
Nanomedicine to Improve Anti-Fungal Treatment II-17
E-Retailing Expands Growth Opportunities II-17
Table 10: Factors Influencing Online Purchase Decision -
Percentage Share Breakdown by Consumer Preferences (includes
corresponding Graph/Chart) II-18
Significance of Foot-Care in Diabetic Population - A Prelude II-18
Table 11: Worldwide Prevalence of Diabetes Mellitus by
Geographic Region: 2013 and 2035 P (includes corresponding
Graph/Chart) II-20

Table 12: World's Health Expenditure on Diabetes by Region
(2013): Spending (in US$ Billion) by People Diagnosed with
Diabetes in the Age Group 20-79 Years to Treat Diabetes and
Manage Complications (includes corresponding Graph/Chart) II-20
Smart Socks - The Future of Diabetic Foot Care? II-21
Obese Population - A Weighty Market Driver II-21
Table 13: Classification of BMI II-22
Table 14: Overweight and Obese Population (Millions) for
2013 in Select Geographic Regions (includes corresponding
Graph/Chart) II-22

Table 15: Obesity Levels in OECD Countries (as a % of Total
Population) for 2013 (includes corresponding Graph/Chart) II-23

Table 16: Global Obesity Levels (2013): Percentage Share
Breakdown of Total Obese/Overweight Population by Leading
Countries (includes corresponding Graph/Chart) II-23
Price - Important Factor in Foot Care Market II-24
Natural Remedies - A Challenge? II-24

3. PRODUCT OVERVIEW II-25
Foot Care - Definition II-25
Foot Care Products Provide Pain Relief and Greater Comfort II-26
Foot Facts and Figures II-26
Foot Care Segments II-27
Foot Care Devices II-27
Arch Bandage II-27
Arch Supports II-27
Corn Pain Relievers II-27
Vibrating Foot Massager/ Warmer II-27
Heated Foot Massagers II-28
Foam Toe Bandages II-28
Foam Toe Separators II-28
Toe Separators II-28
Foot Insole II-28
Open Shoe Insoles II-28
Shoe Insole with Three Layers II-28
Foot Bed Insoles II-29
Gel Insoles II-29
Terrycloth Insoles II-29
Mid-Soles II-29
Outsoles II-29
Gel Insert II-30
Foot Petals II-30
Sandals II-30
Open-toed Shoes II-30
Heels II-30
Vamps II-30
Cellular Cushioning Systems II-31
Memory Foam Pads II-31
Toe Protectors II-31
Orthotics II-31
Treatment for Insoles and Functional Orthotics II-32
Night Splint II-32
Plantar Fasciitis Night Splints II-32
Sock Night Splint II-33
Benefits of Sock Night Splint II-33
Foot Care Medication II-33
Skin Antifungals II-33
Foot Antifungals II-33
Dos and Don’ts of Antifungals II-34
Precautionary Measures II-34
Side Effects of Antifungals II-34
Specialty Lotions II-34
Foot Care Lotion II-34
Essential Oil Blend II-34
Soft Gel Products II-35
Polymer Gel Pad II-35
Design of the Pad II-35
Foot Care Therapies II-35
Spa Foot Therapy II-35
Foot Stress Reliever II-35
Pedicure Methods by Type II-35
Essential Pedicure II-35
French Pedicure II-36
European Pedicure II-36
Salt Glow Pedicure II-36
Aromatherapy Pedicure II-36
Aveda Natural Pedicure II-36
Spa Pedicure II-36
Reflexology Pedicure II-37
New Essence Pedicure II-37
Risk Factors for Foot Problems in Older People II-37
General Foot Problems II-37
Bunion II-37
Hammertoes II-38
Ingrown Nail II-38
Neuropathy II-38
Poor Circulation (Peripheral Vascular Disease) II-39
Spurs II-39
Arch Problems II-39
Corns and Calluses II-39
Corns II-40
Calluses II-40
Table 17: Prevalence of Callus in Select Countries: 2012
(includes corresponding Graph/Chart) II-40
Heel Pain II-41
Neuroma II-41
Osteoarthritis II-41
Warts (Plantars Wart) II-41
Fungal Infection II-41
Foot Wetness and Foot Odor II-41
Causative Factors for Foot Odor II-42
Foot Odor Causes from Continuous Wearing of Shoes and Socks II-42
Material of Sock II-42
Direct Wearing of Shoes II-42
Characteristics of Foot Odor II-42
Foot Odor - An Area of Concern II-42
Methods to Combat Foot Odor II-43
Athlete's Foot II-43
Methods of Preventing Athlete’s Foot II-43
Foot and Heel Injuries II-44
Common Foot and Heel Injuries II-44
Ankle Fracture II-44
Plantar Fasciitis II-44
Achilles Tendonitis II-45
Ruptures of Achilles Tendon II-45
Strains and Sprains II-45
Metatarsalgia II-46
Heel Spurs II-46
Tarsal Tunnel Syndrome II-47
Severs Disease II-47
Common Foot Care Treatments II-47
Foot Baths II-47
Oils and Creams II-47
Exercise II-47
Other Foot Aids II-48
Foot Care Recommendations II-48
Diabetic Foot Care II-48
Daily Routine Check for Diabetics II-49

4. PRODUCT INTRODUCTIONS/INNOVATIONS II-50
Vert Unveils Happy Foot Care Line II-50
Bionova Launches New Foot Care Products II-50
Messe Düsseldorf Unveils CLINIFORCE in Russia II-50
CoValence® Unveils Natural Foot Care Line II-50
Herbacin Unveils Natural Line of Foot Care Products II-50
Herbacin Extends Foot Care Line II-50
Performance Health Unveils Pedigenix II-50

5. RECENT INDUSTRY ACTIVITY II-51
Orthotic Holdings Takes Over Australian Orthotic Group II-51
Bayer to Take Over Consumer Care Division of Merck II-51
GTX Corp and Atlantic Footcare Enter into Manufacturing-
Distribution Deal II-51
Implus Buys Penguin’s Shoe Care Assets II-51
Woodland to Invest INR 12.5 Crore to Develop Foot Care and
Skin Care Products II-51
McPherson’s Takes Over Footcare International II-51
Derma Sciences Acquires MedEfficiency II-51

6. FOCUS ON SELECT PLAYERS II-52
Aetna Felt Corporation (US) II-52
Aetrex Worldwide, Inc. (US) II-52
Alva-Amco Pharmacal Companies, Inc. (US) II-52
Blistex Inc. (US) II-53
Chattem, Inc. (US) II-53
Footcare Express Inc. (US) II-53
Homedics, Inc. (US) II-53
Implus Corporation (US) II-54
Johnson and Johnson (US) II-54
Merck and Co, Inc. (US) II-55
Miracle of Aloe (US) II-55
Novartis AG (Switzerland) II-55
PediFix, Inc. (US) II-56
ProFoot, Inc. (US) II-56
RG Barry Corporation (US) II-56
Spenco Medical Corporation (US) II-57
The W E Bassett Co. (US) II-57
Tweezerman International LLC (US) II-58
Xenna Corporation (US) II-58

7. GLOBAL MARKET PERSPECTIVE II-59
Table 18: World Recent Past, Current and Future Analysis for
Foot Care Products by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (Excl. Japan), Latin America and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-59

Table 19: World Historic Review for Foot Care Products by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(Excl. Japan), Latin America and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-60

Table 20: World 15-Year Perspective for Foot Care Products by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (Excl. Japan), Latin
America and Rest of World Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) II-61

Table 21: World Recent Past, Current and Future Analysis for
Foot Care Devices by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (Excl. Japan), Latin America, and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-62

Table 22: World Historic Review for Foot Care Devices by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(Excl. Japan), Latin America, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-63

Table 23: World 15-Year Perspective for Foot Care Devices by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (Excl. Japan), Latin
America, and Rest of World Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) II-64

Table 24: World Recent Past, Current and Future Analysis for
Foot Care Medication by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (Excl. Japan), Latin America, and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2013 through 2020 (includes
corresponding Graph/Chart) II-65

Table 25: World Historic Review for Foot Care Medication by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(Excl. Japan), Latin America, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2006 through 2012 (includes corresponding
Graph/Chart) II-66

Table 26: World 15-Year Perspective for Foot Care Medication
by Geographic Region - Percentage Breakdown of Dollar Sales
for US, Canada, Japan, Europe, Asia-Pacific (Excl. Japan),
Latin America, and Rest of World Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) II-67


III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
Footwear - A Prelude III-1
Consumer Interest Spurs Foot Care Products III-1
Select Foot Injury Stats III-2
Private Labels Usurp Market III-2
Aging Population Offers Prospects III-2
Table 27: North American Elderly Population by Age Group
(1975-2050) (includes corresponding Graph/Chart) III-3
Surging Diabetic Population - A Business Case III-3
Table 28: US Diabetics Population (2010-2017): Percentage
Population with Diagnosed and Undiagnosed Diabetes
(includes corresponding Graph/Chart) III-4

Table 29: Diabetes Prevalence by Ethnicity (includes
corresponding Graph/Chart) III-4

Table 30: US Diabetes Prevalence (in 000’s) for 2010-2017P
(includes corresponding Graph/Chart) III-5
Alarming Rise in Obesity to Drive Demand III-5
Table 31: Obesity and Overweight Prevalence in US Adults
(2013) (includes corresponding Graph/Chart) III-5

Table 32: Obesity Prevalence in US Adults by Type of
Obesity (2013) (includes corresponding Graph/Chart) III-6

Table 33: US Obesity Prevalence by Age-group (2013)
(includes corresponding Graph/Chart) III-6

Table 34: US Obesity Prevalence 2013 by Annual Income Level
(%)(includes corresponding Graph/Chart) III-6
State-wise Obesity Stats III-6
Table 35: US Obesity Prevalence by Top Cities (% of Total
Population): 2013 (includes corresponding Graph/Chart) III-7

Table 36: US Prevalence of Obesity by Top States (% of
Total Population): 2013 (includes corresponding
Graph/Chart) III-8
Antifungal Medication III-8
List of Select Non-Prescription Antifungals III-8
List of Select Prescription Antifungals III-9
Competitive Landscape III-9
Foot Care Brands III-9
Table 37: Leading Brands in the US Market for Foot Care
Products (2013): Percentage Share Breakdown of Value Sales
Bazuka, Compeed, Daktarin, Lamisil AT, Scholl and Others
(includes corresponding Graph/Chart) III-9
Foot Care Devices III-9
Table 38: Leading Players in the US Foot Care Devices
Market (2013): Percentage Share Breakdown of Value Sales
for Implus, Merck, Private Labels, ProFoot, W.E. Basset
and Others (includes corresponding Graph/Chart) III-10
Foot Care Medication III-10
Table 39: Leading Players in the US Foot Care Medication
Market (2013): Percentage Share Breakdown of Value Sales
for Chattem, Merck, Novartis and Others (includes
corresponding Graph/Chart) III-10
Distribution Scenario III-10
Foot Care Products III-10
Table 40: US Market for Foot Care Products by Sales
Channel (2013): Percentage Share Breakdown of Value Sales
for Major Multiples, Pharmacy and Others (includes
corresponding Graph/Chart) III-11
Product Launches III-11
Strategic Corporate Developments III-11
Key Players III-12
B.Market Analytics III-19
Table 41: US Recent Past, Current and Future Analysis for Foot
Care Products by Product Segment - Devices and Medication
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousands for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-19

Table 42: US Historic Review for Foot Care Products by
Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-20

Table 43: US 15-Year Perspective for Foot Care Products by
Product Segment - Percentage Breakdown of Dollar Sales for
Devices and Medication Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-21

2. CANADA III-22
A.Market Analysis III-22
Current and Future Analysis III-22
Diabetes Foot Ulcer in Canada - A Statistics Review III-22
B.Market Analytics III-23
Table 44: Canadian Recent Past, Current and Future Analysis
for Foot Care Products by Product Segment - Devices and
Medication Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-23

Table 45: Canadian Historic Review for Foot Care Products by
Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-24

Table 46: Canadian 15-Year Perspective for Foot Care
Products by Product Segment - Percentage Breakdown of Dollar
Sales for Devices and Medication Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-25

3. JAPAN III-26
Market Analysis III-26
Table 47: Japanese Recent Past, Current and Future Analysis
for Foot Care Products by Product Segment - Devices and
Medication Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-26

Table 48: Japanese Historic Review for Foot Care Products by
Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-27

Table 49: Japanese 15-Year Perspective for Foot Care
Products by Product Segment - Percentage Breakdown of Dollar
Sales for Devices and Medication Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-28

4. EUROPE III-29
A.Market Analysis III-29
Current and Future Analysis III-29
Diabetes Prevalence in Europe III-29
Table 50: Diabetes Mellitus in Europe (2013 and 2035P):
Percentage Breakdown of Prevalence in Population by Country
(includes corresponding Graph/Chart) III-30

Table 51: Percentage of Population with Diabetes and
Prevalence of Diabetes in the EU (2009-2015E) (includes
corresponding Graph/Chart) III-31
B.Market Analytics III-32
Table 52: European Recent Past, Current and Future Analysis
for Foot Care Products by Geographic Region - France,
Germany, Italy, UK, Spain, Russia and Rest of Europe Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-32

Table 53: European Historic Review for Foot Care Products by
Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Thousands for Years 2006
through 2012 (includes corresponding Graph/Chart) III-33

Table 54: European 15-Year Perspective for Foot Care
Products by Geographic Region - Percentage Breakdown of
Dollar Sales for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-34

Table 55: European Recent Past, Current and Future Analysis
for Foot Care Products by Product Segment - Devices and
Medication Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-35

Table 56: European Historic Review for Foot Care Products by
Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-36

Table 57: European 15-Year Perspective for Foot Care
Products by Product Segment - Percentage Breakdown of Dollar
Sales for Devices and Medication Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-37

4a. FRANCE III-38
A.Market Analysis III-38
Current and Future Analysis III-38
Aging Population Signals Opportunities III-38
Table 58: Percentage Distribution of French Population by
Age Group: 2012 (includes corresponding Graph/Chart) III-38
B.Market Analytics III-39
Table 59: French Recent Past, Current and Future Analysis for
Foot Care Products by Product Segment - Devices and
Medication Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-39

Table 60: French Historic Review for Foot Care Products by
Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-40

Table 61: French 15-Year Perspective for Foot Care Products
by Product Segment - Percentage Breakdown of Dollar Sales
for Devices and Medication Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) III-41

4b. GERMANY III-42
A.Market Analysis III-42
Current and Future Analysis III-42
Product Launches III-42
B.Market Analytics III-43
Table 62: German Recent Past, Current and Future Analysis for
Foot Care Products by Product Segment - Devices and
Medication Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-43

Table 63: German Historic Review for Foot Care Products by
Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-44

Table 64: German 15-Year Perspective for Foot Care Products
by Product Segment - Percentage Breakdown of Dollar Sales
for Devices and Medication Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) III-45

4c. ITALY III-46
Market Analysis III-46
Table 65: Italian Recent Past, Current and Future Analysis for
Foot Care Products by Product Segment - Devices and
Medication Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-46

Table 66: Italian Historic Review for Foot Care Products by
Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-47

Table 67: Italian 15-Year Perspective for Foot Care Products
by Product Segment - Percentage Breakdown of Dollar Sales
for Devices and Medication Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) III-48

4d. THE UNITED KINGDOM III-49
A.Market Analysis III-49
Current and Future Analysis III-49
Diabetic Foot Ulcers in England - An Overview III-49
B.Market Analytics III-50
Table 68: UK Recent Past, Current and Future Analysis for Foot
Care Products by Product Segment - Devices and Medication
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousands for Years 2013 through 2020 (includes
corresponding Graph/Chart) III-50

Table 69: UK Historic Review for Foot Care Products by
Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-51

Table 70: UK 15-Year Perspective for Foot Care Products by
Product Segment - Percentage Breakdown of Dollar Sales for
Devices and Medication Markets for Years 2006, 2014 and 2020
(includes corresponding Graph/Chart) III-52

4e. SPAIN III-53
Market Analysis III-53
Table 71: Spanish Recent Past, Current and Future Analysis for
Foot Care Products by Product Segment - Devices and
Medication Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-53

Table 72: Spanish Historic Review for Foot Care Products by
Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-54

Table 73: Spanish 15-Year Perspective for Foot Care Products
by Product Segment - Percentage Breakdown of Dollar Sales
for Devices and Medication Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) III-55

4f. RUSSIA III-56
A.Market Analysis III-56
Current and Future Analysis III-56
Product Launch III-56
B.Market Analytics III-57
Table 74: Russian Recent Past, Current and Future Analysis for
Foot Care Products by Product Segment - Devices and
Medication Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-57

Table 75: Russian Historic Review for Foot Care Products by
Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-58

Table 76: Russian 15-Year Perspective for Foot Care Products
by Product Segment - Percentage Breakdown of Dollar Sales
for Devices and Medication Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) III-59

4g. REST OF EUROPE III-60
A.Market Analysis III-60
Current and Future Analysis III-60
Novartis Ag (Switzerland)- A Key Player III-60
B.Market Analytics III-61
Table 77: Rest of Europe Recent Past, Current and Future
Analysis for Foot Care Products by Product Segment - Devices
and Medication Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-61

Table 78: Rest of Europe Historic Review for Foot Care
Products by Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-62

Table 79: Rest of Europe 15-Year Perspective for Foot Care
Products by Product Segment - Percentage Breakdown of Dollar
Sales for Devices and Medication Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-63

5. ASIA-PACIFIC III-64
A.Market Analysis III-64
Current and Future Analysis III-64
India and China - Markets with Potential III-64
Table 80: Diabetes Mellitus in Asia-Pacific (2013 and 2035
P): Percentage Breakdown of Prevalence by Select Countries
(includes corresponding Graph/Chart) III-64
B.Market Analytics III-65
Table 81: Asia-Pacific Recent Past, Current and Future
Analysis for Foot Care Products by Geographic Region -
China, India and Rest of Asia-Pacific Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-65

Table 82: Asia-Pacific Historic Review for Foot Care
Products by Geographic Region - China, India and Rest of
Asia-Pacific Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-66

Table 83: Asia-Pacific 15-Year Perspective for Foot Care
Products by Geographic Region - Percentage Breakdown of
Dollar Sales for China, India and Rest of Asia-Pacific
Markets for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-67

Table 84: Asia-Pacific Recent Past, Current and Future
Analysis for Foot Care Products by Product Segment - Devices
and Medication Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-68

Table 85: Asia-Pacific Historic Review for Foot Care
Products by Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-69

Table 86: Asia-Pacific 15-Year Perspective for Foot Care
Products by Product Segment - Percentage Breakdown of Dollar
Sales for Devices and Medication Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-70

5a. CHINA III-71
A.Market Analysis III-71
Current and Future Analysis III-71
Favorable Demographics Bodes Well for Future Market Growth III-71
Table 87: Percentage Distribution of Chinese Population by
Age Group: 2012 (includes corresponding Graph/Chart) III-71
B.Market Analytics III-72
Table 88: Chinese Recent Past, Current and Future Analysis for
Foot Care Products by Product Segment - Devices and
Medication Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-72

Table 89: Chinese Historic Review for Foot Care Products by
Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-73

Table 90: Chinese 15-Year Perspective for Foot Care Products
by Product Segment - Percentage Breakdown of Dollar Sales
for Devices and Medication Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) III-74

5b. INDIA III-75
A.Market Analysis III-75
Current and Future Analysis III-75
Diabetes Scenario III-75
Product Launch III-75
Strategic Corporate Development III-75
B.Market Analytics III-76
Table 91: Indian Recent Past, Current and Future Analysis for
Foot Care Products by Product Segment - Devices and
Medication Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-76

Table 92: Indian Historic Review for Foot Care Products by
Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-77

Table 93: Indian 15-Year Perspective for Foot Care Products
by Product Segment - Percentage Breakdown of Dollar Sales
for Devices and Medication Markets for Years 2006, 2014 and
2020 (includes corresponding Graph/Chart) III-78

5c. REST OF ASIA-PACIFIC III-79
A.Market Analysis III-79
Current and Future Analysis III-79
Strategic Corporate Developments III-79
B.Market Analytics III-80
Table 94: Rest of Asia-Pacific Recent Past, Current and Future
Analysis for Foot Care Products by Product Segment - Devices
and Medication Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-80

Table 95: Rest of Asia-Pacific Historic Review for Foot Care
Products by Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-81

Table 96: Rest of Asia-Pacific 15-Year Perspective for Foot
Care Products by Product Segment - Percentage Breakdown of
Dollar Sales for Devices and Medication Markets for Years
2006, 2014 and 2020 (includes corresponding Graph/Chart) III-82

6. LATIN AMERICA III-83
Market Analysis III-83
Table 97: Latin American Recent Past, Current and Future
Analysis for Foot Care Products by Geographic Region -
Brazil, and Rest of Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Thousands for
Years 2013 through 2020 (includes corresponding Graph/Chart) III-83

Table 98: Latin American Historic Review for Foot Care
Products by Geographic Region - Brazil, and Rest of Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2006 through 2012
(includes corresponding Graph/Chart) III-84

Table 99: Latin American 15-Year Perspective for Foot Care
Products by Geographic Region -Percentage Breakdown of
Dollar Sales for Brazil, and Rest of Latin America Markets
for Years 2006, 2014 and 2020 (includes corresponding
Graph/Chart) III-85

Table 100: Latin American Recent Past, Current and Future
Analysis for Foot Care Products by Product Segment - Devices
and Medication Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-86

Table 101: Latin American Historic Review for Foot Care
Products by Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-87

Table 102: Latin American 15-Year Perspective for Foot Care
Products by Product Segment - Percentage Breakdown of Dollar
Sales for Devices and Medication Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-88

6a. BRAZIL III-89
Market Analysis III-89
Table 103: Brazilian Recent Past, Current and Future Analysis
for Foot Care Products by Product Segment - Devices and
Medication Markets Independently Analyzed with Annual Sales
Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-89

Table 104: Brazilian Historic Review for Foot Care Products
by Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-90

Table 105: Brazilian 15-Year Perspective for Foot Care
Products by Product Segment - Percentage Breakdown of Dollar
Sales for Devices and Medication Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-91

6b. REST OF LATIN AMERICA III-92
Market Analysis III-92
Table 106: Rest of Latin American Recent Past, Current and
Future Analysis for Foot Care Products by Product Segment -
Devices and Medication Markets Independently Analyzed with
Annual Sales Figures in US$ Thousands for Years 2013 through
2020 (includes corresponding Graph/Chart) III-92

Table 107: Rest of Latin American Historic Review for Foot
Care Products by Product Segment - Devices and Medication
Markets Independently Analyzed with Annual Sales Figures in
US$ Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-93

Table 108: Rest of Latin American 15-Year Perspective for
Foot Care Products by Product Segment - Percentage Breakdown
of Dollar Sales for Devices and Medication Markets for Years
2006, 2014 and 2020 (includes corresponding Graph/Chart) III-94

7. REST OF WORLD III-95
Market Analysis III-95
Table 109: Rest of World Recent Past, Current and Future
Analysis for Foot Care Products by Product Segment - Devices
and Medication Markets Independently Analyzed with Annual
Sales Figures in US$ Thousands for Years 2013 through 2020
(includes corresponding Graph/Chart) III-95

Table 110: Rest of World Historic Review for Foot Care
Products by Product Segment - Devices and Medication Markets
Independently Analyzed with Annual Sales Figures in US$
Thousands for Years 2006 through 2012 (includes
corresponding Graph/Chart) III-96

Table 111: Rest of World 15-Year Perspective for Foot Care
Products by Product Segment - Percentage Breakdown of Dollar
Sales for Devices and Medication Markets for Years 2006,
2014 and 2020 (includes corresponding Graph/Chart) III-97


IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 125 (including Divisions/Subsidiaries - 129)

The United States (81)
Canada (2)
Europe (29)
- Germany (6)
- The United Kingdom (9)
- Italy (1)
- Spain (1)
- Rest of Europe (12)
Asia-Pacific (Excluding Japan) (16)
Middle East (1)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update

  • $ 10 995
  • Industry report
  • May 2014
  • by Global Data

PharmaPoint: Hepatitis C Virus - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Summary Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute ...

Antifungal Drugs : Technologies and Global Markets

Antifungal Drugs : Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This report aims to determine the current status of the global human antifungal market and assess its growth potential over the five-year period from 2013 through 2018. It covers approved human therapeutics ...

DNA Vaccines: Technologies and Global Markets

DNA Vaccines: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

This BCC Research study determines the specific applications and global market demand for DNA vaccine products over a five-year period from 2014 to 2019. High growth and market potential segments of the ...

Marketview: Rotavirus Vaccines

June 2014 $ 4 495

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.